EP300 gene transcription is up-regulated by EZH2 inhibitors, p300 drives oncogenic transcriptional reprograming and cancer cell resistance to EZH2 inhibitors, and C646 sensitizes diffuse large B-cell lymphoma cells to EZH2 inhibitors 106. This evidence concerns the gene EZH2 and diffuse large B-cell lymphoma.